Report Detail
Global Acute Myeloid Leukemia Market Size, Status and Forecast 2019-2025
- RnM3463105 |
- 10 July, 2019 |
- Global |
- 93 Pages |
- QYResearch |
- Other
Leukemia are a heterogeneous group of cancers affecting the bone marrow and White Blood Cells (WBC). Leukemia is characterized by the rapid increase of abnormal blood cells growth or blasts, resulting in a decrease in the numbers of healthy, normal fully modified blood cells, leading to the typical symptoms of bleeding, anemia, and high risk of infection.
Primary drivers boosting the growth of acute myeloid leukemia (AML) therapeutics market are minimal but increased prevalence of acute myeloid leukemia (AML), increased drug approval rate for AML, classification of acute myeloid leukemia (AML) as an orphan disease. Over the forecast period, population of people over 65 year is anticipated to increase, which is another key driver for acute myeloid leukemia (AML) therapeutics market.
North America is anticipated to be major contributor to this market accounting maximum percent of share in AML therapeutics market followed by Europe. Slow but constant growth in prevalence for AML in North America is anticipated to fuel the growth in acute myeloid leukemia (AML) therapeutics market. In Asia pacific region, China and India are anticipated to show high growth in acute myeloid leukemia (AML) therapeutics market due to new developments in healthcare infrastructure in the region.
In 2018, the global Acute Myeloid Leukemia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Acute Myeloid Leukemia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Myeloid Leukemia development in United States, Europe and China.
The key players covered in this study
Celgene Corporation
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals
Abbvie
Astellas Pharma
CTI Biopharma Corp
Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Stem Cell Transplant
Targeted Therapy
Others
Market segment by Application, split into
Hospital
Retails Drug Stores
Ambulatory Care Centers
Oncology Centers
Clinics
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Acute Myeloid Leukemia status, future forecast, growth opportunity, key market and key players.
To present the Acute Myeloid Leukemia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Acute Myeloid Leukemia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Acute Myeloid Leukemia Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Chemotherapy
- 1.4.3 Radiation Therapy
- 1.4.4 Stem Cell Transplant
- 1.4.5 Targeted Therapy
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Acute Myeloid Leukemia Market Share by Application (2014-2025)
- 1.5.2 Hospital
- 1.5.3 Retails Drug Stores
- 1.5.4 Ambulatory Care Centers
- 1.5.5 Oncology Centers
- 1.5.6 Clinics
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Acute Myeloid Leukemia Market Size
- 2.2 Acute Myeloid Leukemia Growth Trends by Regions
- 2.2.1 Acute Myeloid Leukemia Market Size by Regions (2014-2025)
- 2.2.2 Acute Myeloid Leukemia Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Acute Myeloid Leukemia Market Size by Manufacturers
- 3.1.1 Global Acute Myeloid Leukemia Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Acute Myeloid Leukemia Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Acute Myeloid Leukemia Market Concentration Ratio (CR5 and HHI)
- 3.2 Acute Myeloid Leukemia Key Players Head office and Area Served
- 3.3 Key Players Acute Myeloid Leukemia Product/Solution/Service
- 3.4 Date of Enter into Acute Myeloid Leukemia Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Acute Myeloid Leukemia Market Size by Type (2014-2019)
- 4.2 Global Acute Myeloid Leukemia Market Size by Application (2014-2019)
5 United States
- 5.1 United States Acute Myeloid Leukemia Market Size (2014-2019)
- 5.2 Acute Myeloid Leukemia Key Players in United States
- 5.3 United States Acute Myeloid Leukemia Market Size by Type
- 5.4 United States Acute Myeloid Leukemia Market Size by Application
6 Europe
- 6.1 Europe Acute Myeloid Leukemia Market Size (2014-2019)
- 6.2 Acute Myeloid Leukemia Key Players in Europe
- 6.3 Europe Acute Myeloid Leukemia Market Size by Type
- 6.4 Europe Acute Myeloid Leukemia Market Size by Application
7 China
- 7.1 China Acute Myeloid Leukemia Market Size (2014-2019)
- 7.2 Acute Myeloid Leukemia Key Players in China
- 7.3 China Acute Myeloid Leukemia Market Size by Type
- 7.4 China Acute Myeloid Leukemia Market Size by Application
8 Japan
- 8.1 Japan Acute Myeloid Leukemia Market Size (2014-2019)
- 8.2 Acute Myeloid Leukemia Key Players in Japan
- 8.3 Japan Acute Myeloid Leukemia Market Size by Type
- 8.4 Japan Acute Myeloid Leukemia Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Acute Myeloid Leukemia Market Size (2014-2019)
- 9.2 Acute Myeloid Leukemia Key Players in Southeast Asia
- 9.3 Southeast Asia Acute Myeloid Leukemia Market Size by Type
- 9.4 Southeast Asia Acute Myeloid Leukemia Market Size by Application
10 India
- 10.1 India Acute Myeloid Leukemia Market Size (2014-2019)
- 10.2 Acute Myeloid Leukemia Key Players in India
- 10.3 India Acute Myeloid Leukemia Market Size by Type
- 10.4 India Acute Myeloid Leukemia Market Size by Application
11 Central & South America
- 11.1 Central & South America Acute Myeloid Leukemia Market Size (2014-2019)
- 11.2 Acute Myeloid Leukemia Key Players in Central & South America
- 11.3 Central & South America Acute Myeloid Leukemia Market Size by Type
- 11.4 Central & South America Acute Myeloid Leukemia Market Size by Application
12 International Players Profiles
- 12.1 Celgene Corporation
- 12.1.1 Celgene Corporation Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Acute Myeloid Leukemia Introduction
- 12.1.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2014-2019)
- 12.1.5 Celgene Corporation Recent Development
- 12.2 Cephalon
- 12.2.1 Cephalon Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Acute Myeloid Leukemia Introduction
- 12.2.4 Cephalon Revenue in Acute Myeloid Leukemia Business (2014-2019)
- 12.2.5 Cephalon Recent Development
- 12.3 Clavis Pharma
- 12.3.1 Clavis Pharma Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Acute Myeloid Leukemia Introduction
- 12.3.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2014-2019)
- 12.3.5 Clavis Pharma Recent Development
- 12.4 Eisai
- 12.4.1 Eisai Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Acute Myeloid Leukemia Introduction
- 12.4.4 Eisai Revenue in Acute Myeloid Leukemia Business (2014-2019)
- 12.4.5 Eisai Recent Development
- 12.5 Genzyme Corporation
- 12.5.1 Genzyme Corporation Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Acute Myeloid Leukemia Introduction
- 12.5.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2014-2019)
- 12.5.5 Genzyme Corporation Recent Development
- 12.6 Sunesis Pharmaceuticals
- 12.6.1 Sunesis Pharmaceuticals Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Acute Myeloid Leukemia Introduction
- 12.6.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2014-2019)
- 12.6.5 Sunesis Pharmaceuticals Recent Development
- 12.7 Abbvie
- 12.7.1 Abbvie Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Acute Myeloid Leukemia Introduction
- 12.7.4 Abbvie Revenue in Acute Myeloid Leukemia Business (2014-2019)
- 12.7.5 Abbvie Recent Development
- 12.8 Astellas Pharma
- 12.8.1 Astellas Pharma Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Acute Myeloid Leukemia Introduction
- 12.8.4 Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2014-2019)
- 12.8.5 Astellas Pharma Recent Development
- 12.9 CTI Biopharma Corp
- 12.9.1 CTI Biopharma Corp Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Acute Myeloid Leukemia Introduction
- 12.9.4 CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2014-2019)
- 12.9.5 CTI Biopharma Corp Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Acute Myeloid Leukemia . Industry analysis & Market Report on Acute Myeloid Leukemia is a syndicated market report, published as Global Acute Myeloid Leukemia Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Acute Myeloid Leukemia market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
